1. Home
  2. FSLY vs TLX Comparison

FSLY vs TLX Comparison

Compare FSLY & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastly Inc.

FSLY

Fastly Inc.

HOLD

Current Price

$17.69

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.05

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLY
TLX
Founded
2011
2015
Country
United States
Australia
Employees
N/A
1184
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.6B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FSLY
TLX
Price
$17.69
$10.05
Analyst Decision
Hold
Strong Buy
Analyst Count
8
4
Target Price
$18.00
$21.13
AVG Volume (30 Days)
6.5M
192.7K
Earning Date
05-06-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
27.19
N/A
EPS
N/A
N/A
Revenue
$624,018,000.00
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
$10.73
N/A
P/E Ratio
N/A
$150.33
Revenue Growth
14.78
N/A
52 Week Low
$6.29
$6.28
52 Week High
$34.82
$16.95

Technical Indicators

Market Signals
Indicator
FSLY
TLX
Relative Strength Index (RSI) 43.70 57.09
Support Level $16.06 $10.06
Resistance Level $20.27 $10.33
Average True Range (ATR) 1.64 0.27
MACD 0.10 0.09
Stochastic Oscillator 18.24 95.24

Price Performance

Historical Comparison
FSLY
TLX

About FSLY Fastly Inc.

Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: